Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.
about
Apolipoprotein A-I and CancerPlant sterols as anticancer nutrients: evidence for their role in breast cancerThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsHigh-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections.Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.HDL cholesterol and cancer risk among patients with type 2 diabetes.High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma.Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity.Plasma lipid levels and colorectal adenoma riskDiabetes, insulin and cancer risk.Hypochlorite-induced oxidative stress elevates the capability of HDL in promoting breast cancer metastasis.A nutrient-dense, high-fiber, fruit-based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2-wk trial.Effects of Vitellaria paradoxa (C.F. Gaertn.) aqueous leaf extract administration on Salmonella typhimurium-infected ratsMetabolic syndrome and risk of cancer: a systematic review and meta-analysis.Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma.Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Oxidative stress and plasma lipoproteins in cancer patients.Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.Lower serum levels of total cholesterol are associated with higher urinary levels of 8-hydroxydeoxyguanosine.ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer.Anti-inflammatory Function of High-Density Lipoproteins via Autophagy of IκB Kinase.Predictive value of chemotherapy-related high-density lipoprotein cholesterol (HDL) elevation in patients with colorectal cancer receiving adjuvant chemotherapy: an exploratory analysis of 851 cases.The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review.Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.Apolipoproteins, lipids and risk of cancer.Insights into the relationships between diabetes, prediabetes, and cancer.High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells.Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancerSynergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.Evaluation of serum high-density lipoprotein cholesterol levels as a prognostic factor in gastric cancer patients.Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study.Efficacy of lycopene on modulation of renal antioxidant enzymes, ACE and ACE gene expression in hyperlipidaemic rats.High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation.Pretreatment direct bilirubin and total cholesterol are significant predictors of overall survival in advanced non-small-cell lung cancer patients with EGFR mutations.Serum lipids and risk of obesity-related cancers in postmenopausal women.Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy.Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study.
P2860
Q26776188-76F6703B-8FE6-4C6B-9817-CB2F32F6826BQ26861053-6B1B1A73-A7E2-4685-B551-4879BF767FE2Q28388695-42159876-2C8C-4DED-B009-3E9CF467B303Q31127155-E2C15DBA-C6E5-46E1-8024-AD6A0FD77EA0Q33837659-0D8982FA-AD4E-409B-8364-B5CC54BD5296Q33905987-C4FB1E54-A1AF-43D7-ABF5-670F3D3EE6F3Q34545361-99EA2CA0-BF6F-42B6-BC93-26637EF3BF52Q34558777-6553D843-70FB-43E6-BEE6-F9AE966620E4Q34572361-24B37F77-5FDA-46E3-AC4A-5722F2672A6FQ34639797-6C0D8143-78DC-44B8-BC94-D73EDFD2A918Q35141775-8CFA3EF5-494D-43E5-89A7-500233F9C938Q35222154-AB2F953C-9B15-47AB-9EAF-47F1D1C8CC37Q35906970-26B476A3-29C3-4995-B13C-707CDB68E887Q35927813-2AD3A317-5DAB-4910-9CCF-A261AED6CBD1Q36117465-92FDD366-9CC8-4DC9-8047-7E638BF7287CQ36317520-91F78749-0EAA-4578-802A-E40396F3C54EQ36334568-FD5D139E-6C16-4DA6-8968-1759020D0DBBQ36514558-C4255B1B-613A-4071-B31E-00DE6D271BFFQ36584255-C64E67A3-FF17-408E-B725-F8286158C216Q36934879-AE2D0533-D9AB-42CE-9EC8-2692777289CCQ37147231-16B36901-BD21-45C9-8563-98369AC60868Q37363819-3828C15E-851A-43F4-829C-60D557DCDA5DQ37390177-509598A6-F348-4810-9EEE-632987D15B53Q37634922-4F675448-28BB-4D3B-A47A-93C89B43CFEBQ37636796-ACA83D7D-B2B8-47DD-9F6E-CAFC0EF7102EQ38151145-E11E516D-107E-48C6-9A6E-0B36329191FCQ38388443-05E45632-D103-4C04-B999-2D088AC10E8AQ38916878-0022A919-0355-43C2-8A26-2900F3DB7479Q39063925-09B3ED99-9ECC-4E47-A9B6-E5DC0D6DBCDCQ39497245-24E2EA8A-85F9-4F7E-A3B7-8B534A36B273Q42700846-C85C40EE-5566-4B2A-BF59-548DD5AD0A80Q44107851-3A6D8FD7-79C9-46EB-BD77-4EC4FAF0C44AQ44371836-C7754616-9427-4BE8-98EF-6832FC5CC387Q45023613-DAF7EC3A-DDFE-4363-BC4F-53C133A59FA3Q47993128-9DAFC1B7-295D-40DA-9DCF-D3400DCC5EC3Q48113241-A5CBD24E-6D85-4145-B65C-2B0E67004A34Q48648136-478EADB1-C841-47C8-BF7F-5D6020330BEFQ49344024-E0F7D08E-8639-4422-97CB-A715E8E9A03DQ49528648-C98FD072-050B-466F-9BE4-957B33673F9CQ51194118-611D3175-E2A7-4F63-9D68-CA1AA6D06CD8
P2860
Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Baseline and on-treatment high ...... als of lipid-altering therapy.
@en
Baseline and on-treatment high ...... als of lipid-altering therapy.
@nl
type
label
Baseline and on-treatment high ...... als of lipid-altering therapy.
@en
Baseline and on-treatment high ...... als of lipid-altering therapy.
@nl
prefLabel
Baseline and on-treatment high ...... als of lipid-altering therapy.
@en
Baseline and on-treatment high ...... als of lipid-altering therapy.
@nl
P2093
P1476
Baseline and on-treatment high ...... als of lipid-altering therapy.
@en
P2093
Alawi A Alsheikh-Ali
Haseeb Jafri
Richard H Karas
P304
P356
10.1016/J.JACC.2009.12.069
P407
P577
2010-06-01T00:00:00Z